ALLO CapEx to Revenue

Allogene Therapeutics Inc · CapEx to Revenue

ALLO logo

ALLO CapEx to Revenue

Current (TTM)8.66%
ALLO CapEx/Revenue (0.00% → 8.66%)
High-resolution chart · PNG

ALLO capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Allogene Therapeutics Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0%
3,154.5455%
1,595.7895%
3,327.5641%
18.7976%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.